MOVE Grant Program

The South Carolina Research Authority (SCRA) Member Companies may apply for a variety of non-dilutive grants, each with its own eligibility and review criteria. The Academic Startup Grant is focused on startups advancing intellectual property from institutions of higher education. Managed by the Academic Innovations team, the objective of the Academic Startup Grant is to provide earlystage funding to academic startups to support one or more critical milestones towards commercialization and to advance the company’s pursuit of follow-on funding. Key milestones include developing the technology past the minimum viable product (MVP) and demonstrating product-market fit, in the DEVELOP stage of startup development. Academic Startup Grants provide funding for up to $25,000.

Every month, we select a business owner in the US as a Freed Fellow. Each Fellow receives a $500 grant to invest in their existing business. No strings attached. No equity required. Everyone who submits a feedback request also receives two months free inside Freed Studio—our virtual community designed to help you grow your email list and turn subscribers into sales. Freed Fellows are also eligible to receive an additional end-of-year grant of $2,500.

Purpose: The purpose of the grant is to help mitigate the impact of wolves on livestock producers in California. The Wolf-Livestock Compensation Grant Program has established three primary areas of need and compensation; direct livestock loss from wolf depredation, the use nonlethal deterrent tools, and the compensation for indirect loss or affects from wolves on livestock. Description: The Wolf-Livestock Compensation Grant Program has three “prongs”, or potential grant opportunities, for eligible applicants: direct loss compensation, nonlethal deterrent methods support, and indirect loss compensation. This grant opportunity involves the first prong, direct loss compensation, in which producers can be compensated for direct livestock loss (death, injury) due to confirmed or probable wolf depredation. Wolf depredation is determined during an investigation and documented by CDFW on a Livestock Loss Determination form. Each reported depredation incident is unique and requires a case-by-case analysis of the evidence, context, and other factors that inform the determination process. CDFW strives to conduct investigations as soon as reasonably possible to preserve physical evidence and gather information from producers and potential eyewitnesses. Wolf depredation is “confirmed” when there is physical evidence that an animal was injured or killed by a wolf and “probable” when there is sufficient evidence to suggest wolf predation (e.g., evidence of predation and evidence that wolves were likely present at the time of injury or death), but not enough evidence to confirm it. Upon issuance of compensation for a direct loss, producers will be expected to consult with the Department to evaluate and implement a deterrent strategy that may be beneficial in reducing wolf-livestock conflict. The deterrent tools and/or actions implemented as part of this strategy may be eligible for compensation under the program’s second prong, if and when sufficient funds are available.

Boost Harlingen is a small business matching grant program offered by the Harlingen Economic Development Corporation (HEDC) which is designed to assist businesses in expanding their production capabilities through strategic marketing efforts. Eligible businesses may receive up to $1,500 in matching funds per year, subject to fund availability. No funds are provided upfront. Eligible pre-approved marketing efforts must be completed by August 31, 2026. The matching reimbursement payment is provided when the project is completed, subject to the terms of the grant and final approval from the HEDC Board of Directors. Program eligibility is discretionary and may be discontinued by the HEDC Board of Directors or Harlingen City Commission at any time.

This funding opportunity announcement (FOA) encourages the development and validation of animal models and human/animal tissue ex vivo systems that recapitulate the phenotypic and physiologic characteristics of a defined neurological or neuromuscular disorder. The goal of this FOA is to promote a significant improvement in the translational relevance of animal models or ex vivo systems that will be utilized to facilitate future development of neurotherapeutics. Ideally, models proposed for this FOA would have the potential to provide feasible and meaningful assessments of efficacy following therapeutic intervention that would be applicable in both preclinical and clinical settings. This FOA is part of a suite of Innovation Grants to Nurture Initial Translational Efforts (IGNITE) Program focused on enabling the exploratory and early stages of drug discovery.